[VIVO] YoY Annual Result on 30-Sep-2021 [#FY]

Stock
[VIVO] Meridian Bioscience, Inc.
Announcement Date
23-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#FY]
Profit Trend
YoY- 54.61%
Quarter Report
VIVO's Result
VIVO's Financial Summary
View:
Show?
Annual Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 333,018 317,896 253,667 201,014 213,571 200,771 196,082 9.22%
PBT 54,317 90,451 59,293 31,557 30,380 36,429 50,644 1.17%
Tax 11,858 19,044 13,107 7,175 6,531 14,872 18,415 -7.07%
NP 42,459 71,407 46,186 24,382 23,849 21,557 32,229 4.69%
Tax Rate -21.83% -21.05% -22.11% -22.74% -21.50% -40.82% -36.36% -
Total Cost 290,559 246,489 207,481 176,632 189,722 179,214 163,853 10.01%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 12.75 22.46 18.21 12.13 11.17 10.74 16.44 -4.14%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS 0.96 1.62 1.07 0.57 0.56 0.51 0.77 3.74%
EPS Diluted 0.96 1.62 1.07 0.57 0.56 0.51 0.76 3.96%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.